Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

33.36
Delayed Data
As of Apr 29
 -1.89 / -5.36%
Today’s Change
25.27
Today|||52-Week Range
263.81
-67.18%
Year-to-Date

Today’s Trading

Previous close35.25
Today’s open36.64
Day’s range32.33 - 37.22
Volume35,688,308
Average volume (3 months)19,905,747
Market cap$11.4B
Dividend yield--
Data as of 4:01pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+23.32%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+43.22%
P/E ratio13.8
Price/Sales5.93
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+1.63+2.90%
INCYIncyte Corp-0.07-0.10%
JAZZJazz Pharmaceuticals...-1.30-0.86%
BMRNBiomarin Pharmaceuti...-0.42-0.49%
Data as of 4:14pm ET, 04/29/2016

Financials

Next reporting dateMay 2, 2016
EPS forecast (this quarter)$1.37
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
J. Michael Pearson
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Qubec

Forecasts

Partner Offers

Search for Jobs